Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

CVX-060 MAb evaluated in solid tumors in first-in-human trial

June 11, 2010

ArQule's ARQ-197 shows promise in phase I/II trials in solid tumors

June 11, 2010

HSP 90 inhibitors show potent activity in preclinical models of CRPC

June 11, 2010

Engrailed-2 proposed as diagnostic biomarker for prostate cancer

June 10, 2010

Inhaled formoterol fumarate/glycopyrrolate is safe in healthy subjects

June 10, 2010

QBI-139 enters phase I trial in advanced/refractory solid tumors

June 10, 2010

Simvastatin/ezetimibe combination promotes tumor growth in prostate cancer model

June 10, 2010

Potent inhibitors identified of GIST-relevant kinases

June 10, 2010

Serum bilirubin modulates response to bucindolol in patients with heart failure

June 10, 2010

Bortezomib linked to heart failure in patients with multiple myeloma

June 9, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...